These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32453512)

  • 1. Complete wound closure following a single topical application of a novel autologous homologous skin construct: first evaluation in an open-label, single-arm feasibility study in diabetic foot ulcers.
    Armstrong DG; Orgill DP; Galiano R; Glat PM; Carter M; Zelen CM; Li WW
    Int Wound J; 2020 Oct; 17(5):1366-1375. PubMed ID: 32453512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open-label Venous Leg Ulcer Pilot Study Using a Novel Autolologous Homologous Skin Construct.
    Armstrong DG; Orgill DP; Galiano RD; Glat PM; Carter MJ; Zelen CM
    Plast Reconstr Surg Glob Open; 2020 Jul; 8(7):e2972. PubMed ID: 32802665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical Erythropoietin Accelerates Wound Closure in Patients with Diabetic Foot Ulcers: A Prospective, Multicenter, Single-Blind, Randomized, Controlled Trial.
    Hamed S; Ullmann Y; Belokopytov M; Shoufani A; Kabha H; Masri S; Feldbrin Z; Kogan L; Kruchevsky D; Najjar R; Liu PY; Kerihuel JC; Akita S; Teot L
    Rejuvenation Res; 2021 Aug; 24(4):251-261. PubMed ID: 33504262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective, Descriptive Study to Assess the Clinical Benefits of Using Calendula officinalis Hydroglycolic Extract for the Topical Treatment of Diabetic Foot Ulcers.
    Buzzi M; de Freitas F; Winter M
    Ostomy Wound Manage; 2016 Mar; 62(3):8-24. PubMed ID: 26978856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An observational pilot study using a purified reconstituted bilayer matrix to treat non-healing diabetic foot ulcers.
    Armstrong DG; Orgill DP; Galiano RD; Glat PM; Kaufman JP; Carter MJ; Zelen CM
    Int Wound J; 2020 Aug; 17(4):966-973. PubMed ID: 32266774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, randomized controlled clinical trial evaluating the effects of a novel autologous heterogeneous skin construct in the treatment of Wagner one diabetic foot ulcers: Final analysis.
    Armstrong DG; Orgill DP; Galiano R; Glat PM; Didomenico L; Sopko NA; Swanson EW; Sigal F; Snyder R; Li WW; Carter M; Zelen CM
    Int Wound J; 2023 Dec; 20(10):4083-4096. PubMed ID: 37402533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
    Driver VR; Reyzelman A; Kawalec J; French M
    Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, multicentre, open-label, single-arm clinical trial for treatment of chronic complex diabetic foot wounds with exposed tendon and/or bone: positive clinical outcomes of viable cryopreserved human placental membrane.
    Frykberg RG; Gibbons GW; Walters JL; Wukich DK; Milstein FC
    Int Wound J; 2017 Jun; 14(3):569-577. PubMed ID: 27489115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multicenter, Blinded, Randomized Controlled Clinical Trial Evaluating the Effect of Omega-3-Rich Fish Skin in the Treatment of Chronic, Nonresponsive Diabetic Foot Ulcers.
    Lullove EJ; Liden B; Winters C; McEneaney P; Raphael A; Lantis Ii JC
    Wounds; 2021 Jul; 33(7):169-177. PubMed ID: 33872197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a novel purified reconstituted bilayer matrix for treatment of chronic diabetic foot ulcers: a retrospective case series.
    Isaac AL; Tritto M
    Wounds; 2023 Jan; 35(1):E29-E34. PubMed ID: 36749995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
    Zelen CM; Orgill DP; Serena T; Galiano R; Carter MJ; DiDomenico LA; Keller J; Kaufman J; Li WW
    Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Punch Grafting for the Management of Hard-to-Heal Diabetic Foot Ulcers: A Prospective Case Series.
    García-Madrid M; Sanz-Corbalán I; Tardáguila-García A; Molines-Barroso RJ; López-Moral M; Lázaro-Martínez JL
    Int J Low Extrem Wounds; 2023 Sep; 22(3):542-547. PubMed ID: 34255558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot feasibility study of non-cultured autologous skin cell suspension for healing diabetic foot ulcers.
    Rashid ST; Cavale N; Bowling FL
    Wound Repair Regen; 2020 Nov; 28(6):719-727. PubMed ID: 32686262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical Esmolol Hydrochloride as a Novel Treatment Modality for Diabetic Foot Ulcers: A Phase 3 Randomized Clinical Trial.
    Rastogi A; Kulkarni SA; Agarwal S; Akhtar M; Arsule S; Bhamre S; Bhosle D; Desai S; Deshmukh M; Giriraja KV; Jagannath J; Kashiva RY; Kesavan R; Khandelwal D; Kolte S; Kongara S; Darivemula AK; Madhusudan C; Pyare Saheb Qureshi MAH; Ramu M; Rathod G; Yalamanchi SR; Shakya S; Shetty P; Singh S; Deshpande SK; Viswanathan V; Unnikrishnan AG
    JAMA Netw Open; 2023 May; 6(5):e2311509. PubMed ID: 37184839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator.
    Cazzell S; Vayser D; Pham H; Walters J; Reyzelman A; Samsell B; Dorsch K; Moore M
    Wound Repair Regen; 2017 May; 25(3):483-497. PubMed ID: 28544150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre, randomised controlled clinical trial evaluating the effects of a novel autologous, heterogeneous skin construct in the treatment of Wagner one diabetic foot ulcers: Interim analysis.
    Armstrong DG; Orgill DP; Galiano R; Glat PM; Didomenico L; Reyzelman A; Snyder R; Li WW; Carter M; Zelen CM
    Int Wound J; 2022 Jan; 19(1):64-75. PubMed ID: 33942506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers.
    Tettelbach W; Cazzell S; Sigal F; Caporusso JM; Agnew PS; Hanft J; Dove C
    Int Wound J; 2019 Feb; 16(1):122-130. PubMed ID: 30246926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a porcine peritoneum-derived matrix in diabetic foot ulcer treatment: a pilot study.
    Ai-Jalodi O; Sabo M; Patel K; Bullock N; Serena L; Breisinger K; Serena TE
    J Wound Care; 2021 Feb; 30(Sup2):S18-S23. PubMed ID: 33573495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Diabetic Foot Ulcers With Inforatio Technique to Promote Wound Healing: A Feasibility Trial.
    Moeini S; Gottlieb H; Jørgensen TS; Larsen MRB; Brorson S
    Int J Low Extrem Wounds; 2023 Jun; 22(2):241-250. PubMed ID: 33909504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.